Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

5AM Venture Management, LLC 13F Holdings -- Portfolio & Top Positions (2026-03-31)

5AM Venture Management, LLC (CIK 1799883) reported $360.2M across 19 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ERAS ($56.4M, 15.66%), TRDA ($51.2M, 14.21%), TYRA ($39.4M, 10.94%), CAMP ($25.9M, 7.19%), CNTA ($23.1M, 6.41%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1ERASERASCA INC$56.4M15.66%3.5MTrimmed
2TRDAENTRADA THERAPEUTICS INC$51.2M14.21%4.1MHold
3TYRATYRA BIOSCIENCES INC$39.4M10.94%1.0MHold
4CAMPCAMP4 THERAPEUTICS CORP$25.9M7.19%5.9MHold
5CNTACENTESSA PHARMACEUTICALS PLC$23.1M6.41%580,945Hold
6PHVSPHARVARIS N V$22.5M6.26%797,600Hold
7MAPLIGHT THERAPEUTICS INC$19.3M5.36%950,011Hold
8TECXTECTONIC THERAPEUTIC INC$18.8M5.21%606,660Hold
9CLDXCELLDEX THERAPEUTICS INC NEW$15.8M4.38%497,270Hold
10ARTVARTIVA BIOTHERAPEUTICS INC$15.2M4.21%2.4MHold
11EYPTEYEPOINT INC$13.5M3.76%1.1MHold
12SRZNSURROZEN INC$11.3M3.13%387,500Hold
13ZNTLZENTALIS PHARMACEUTICALS INC$9.2M2.56%3.9MHold
14GHRSGH RESEARCH PLC$8.1M2.24%572,665Hold
15TARAPROTARA THERAPEUTICS INC$7.1M1.98%1.4MHold
16BHVNBIOHAVEN LTD$6.3M1.74%738,972Hold
17ALXOALX ONCOLOGY HLDGS INC$6.1M1.70%3.1MNew
18SKYESKYE BIOSCIENCE INC$6.0M1.65%9.7MHold
19RLYBRALLYBIO CORP$2.6M0.73%291,788New
20SLNSILENCE THERAPEUTICS PLC$2.5M0.70%476,200Hold
21ELVNENLIVEN THERAPEUTICS INC$00.00%0Exited
22RLYBRALLYBIO CORP$00.00%0Exited
23VRDNVIRIDIAN THERAPEUTICS INC$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-03-31